Federal contractor · BURLINGTON, VT

GREEN MOUNTAIN ANTIBODIES INC

GREEN MOUNTAIN ANTIBODIES INC received $60.2K in federal contract obligations in FY2026, on 1 awards. Since FY2017: $1.4M. Its largest customer was Agricultural Research Service ($60.2K).

Obligations · FY2026
$60.2K
New awards
1
Sole-source
0.0%
Single offer
0.0%
UEI
FVQDNC5PJ5P3
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 31.7KFY2017
  2. -3.7KFY2018
  3. 11.9KFY2019
  4. 137.1KFY2020
  5. 325.2KFY2021
  6. 257.9KFY2022
  7. 265.6KFY2023
  8. 273.3KFY2024
  9. 0FY2025
  10. 60.2KFY2026

Top buying agencies

Obligations in FY2026.

  1. Agricultural Research Service$60.2K100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Professional services$60.2K100%

Where the work was performed

  1. Clarke County, GA$60.2K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. MONOCLONAL ANTIBODIES ARE A BIOLOGICAL REAGENT THAT MUST BE CUSTOM MADE BY SPECIALIZED VENDORS. THEY ARE PREPARED TO THE SPECIFICATIONS FOR THEIR SPECIFIC USE. HERE THEY WILL BE USED AS A CORE COMPONENT OF A DIAGNOSTIC TEST FOR H5 HIGHLY PATHOGENIC A$60.2K
    Agricultural Research Service· Clarke County, GA· Professional services· Nov 20, 2025 – Apr 7, 2026· 1232SA26P0005

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

GREEN MOUNTAIN ANTIBODIES INC received $0 in federal assistance in FY2026, on 0 actions (0 new awards), −100% vs FY2025.

Assistance · FY2026
$0
New awards
0
Actions
0

Assistance by fiscal year

  1. 239.6KFY2025

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2025.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 2 markets (agency × industry), FY2024–FY2026.

  1. 60 DEGREES PHARMACEUTICALS, INC.$282.9K
    WASHINGTON, DC · 82% of this company's obligations are in markets they both serveDefense Health Agency · Pharmaceutical and medicine manufacturing
  2. EDGE BIOSYSTEMS INC$322.8K−51% in FY2026
    SAN JOSE, CA · 82% of this company's obligations are in markets they both serveDefense Health Agency · Pharmaceutical and medicine manufacturing
  3. VALUE DRUG, LIMITED$235.7K
    HONOLULU, HI · 71% of this company's obligations are in markets they both serveDefense Health Agency · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.